Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a703695f605ded296e3ff7b8bb45ea88 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate |
2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27de239c5d26dc1aec3cf882e7db2c5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01ac01792ce7e42ed114898610120a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38b756c02a43233f302aa08a2668b2e |
publicationDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
GB-2520483-A |
titleOfInvention |
A probiotic composition for treating picornavirus infection and its use thereof |
abstract |
A composition used for treating picornavirus infection comprises at least one of the following bacterial strains: Lactobacillus paracasei GMNL-33 with the deposition number CCTCC M 206133, Lactobacillus reuteri GMNL-89 with the deposition number CCTCC M 207154 and Lactobacillus casei GMNL-277 with the deposition number CCTCC M 2013197, and a pharmaceutically acceptable vehicle. The invention also relates to the isolated Lactobacillus strain Lactobacillus casei GMNL-277. The strains may be used in pharmaceutical compositions and food products for treating picornovirus infection, and in particular infection by the enterovirus EV-71. The mechanism of action is inhibition of virus infection by binding of the probiotic bacteria to viruses. |
priorityDate |
2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |